Yi-Ping Hung

2PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai

|Jul 05, 2022
A generational comparison for unfavorable cancer of unknown primary in a single institute over 20 years.

Cheng-Yu Tang, Jen-Fan Hang, Yi-Ping Hung

Pageof 1